{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,10]],"date-time":"2026-09-10T03:37:09Z","timestamp":1789011429636,"version":"build-2803163510"},"reference-count":21,"publisher":"Informa UK Limited","issue":"5","license":[{"start":{"date-parts":[[2023,3,29]],"date-time":"2023-03-29T00:00:00Z","timestamp":1680048000000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"funder":[{"DOI":"10.13039\/100004312","name":"Eli Lilly and Company","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100004312","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["www.tandfonline.com"],"crossmark-restriction":true},"short-container-title":["Leukemia &amp; Lymphoma"],"published-print":{"date-parts":[[2023,4,16]]},"DOI":"10.1080\/10428194.2023.2190436","type":"journal-article","created":{"date-parts":[[2023,3,29]],"date-time":"2023-03-29T03:02:28Z","timestamp":1680058948000},"page":"1005-1016","update-policy":"https:\/\/doi.org\/10.1080\/tandf_crossmark_01","source":"Crossref","is-referenced-by-count":18,"title":["Clinical outcomes among patients with chronic lymphocytic leukemia (CLL)\/small lymphocytic lymphoma (SLL) who received treatment with a covalent BTK and BCL2 inhibitor in the United States: a real-world database study"],"prefix":"10.1080","volume":"64","author":[{"given":"Toby A.","family":"Eyre","sequence":"first","affiliation":[{"name":"Oxford Cancer and Hematology Centre, Oxford University NHS Foundation Trust, Oxford, UK"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lisa M.","family":"Hess","sequence":"additional","affiliation":[{"name":"Eli Lilly and Company, Indianapolis, IN, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tomoko","family":"Sugihara","sequence":"additional","affiliation":[{"name":"Syneos Health, Inc, Morrisville, NC, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Dan","family":"He","sequence":"additional","affiliation":[{"name":"Syneos Health, Inc, Morrisville, NC, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Manoj","family":"Khanal","sequence":"additional","affiliation":[{"name":"Eli Lilly and Company, Indianapolis, IN, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"John M.","family":"Pagel","sequence":"additional","affiliation":[{"name":"Loxo@Lilly, Indianapolis, IN, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Richard A.","family":"Walgren","sequence":"additional","affiliation":[{"name":"Loxo@Lilly, Indianapolis, IN, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Paolo","family":"B. Abada","sequence":"additional","affiliation":[{"name":"Loxo@Lilly, Indianapolis, IN, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Heiko","family":"Konig","sequence":"additional","affiliation":[{"name":"Loxo@Lilly, Indianapolis, IN, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lindsey E.","family":"Roeker","sequence":"additional","affiliation":[{"name":"Memorial Sloan Kettering Cancer Center, New York, NY, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Anthony","family":"Mato","sequence":"additional","affiliation":[{"name":"Memorial Sloan Kettering Cancer Center, New York, NY, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"301","published-online":{"date-parts":[[2023,3,29]]},"reference":[{"key":"CIT0001","doi-asserted-by":"publisher","DOI":"10.1177\/2040620721989588"},{"key":"CIT0002","doi-asserted-by":"publisher","DOI":"10.1016\/S0140-6736(10)61381-5"},{"key":"CIT0003","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMoa1400376"},{"key":"CIT0004","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMoa1509388"},{"key":"CIT0005","unstructured":"FDA [Internet]. Drugs@FDA: FDA-Approved Drugs; Calquence 2019. Available from https:\/\/www.accessdata.fda.gov\/scripts\/cder\/daf\/index.cfm?event=overview.process&ApplNo=210259."},{"key":"CIT0006","unstructured":"FDA [Internet]. Drugs@FDA: FDA-Approved Drugs; Imbruvica 2018. Available from https:\/\/www.accessdata.fda.gov\/scripts\/cder\/daf\/index.cfm?event=overview.process&ApplNo=210563."},{"key":"CIT0007","unstructured":"FDA [Internet]. Drugs@FDA: FDA-Approved Drugs; Brukinsa 2023. Available from: https:\/\/www.accessdata.fda.gov\/drugsatfda_docs\/label\/2023\/213217s007lbl.pdf."},{"key":"CIT0008","unstructured":"FDA [Internet]. Drugs@FDA: FDA-Approved Drugs; Venclexa 2016. Available from: https:\/\/www.accessdata.fda.gov\/drugsatfda_docs\/label\/2016\/208573s000lbl.pdf."},{"key":"CIT0009","doi-asserted-by":"publisher","DOI":"10.1182\/blood-2018-184"},{"key":"CIT0010","unstructured":"NCCN [Internet]. NCCN clinical practice guidelines in oncology: chronic lymphocytic leukemia\/small lymphocytic leukemia, Version 2. 2023. 2023, www.nccn.org, cited on February 17, 2023."},{"key":"CIT0011","doi-asserted-by":"publisher","DOI":"10.1097\/01.HS9.0000845496.26774.0b"},{"key":"CIT0012","doi-asserted-by":"publisher","DOI":"10.1016\/j.clml.2022.09.007"},{"key":"CIT0013","doi-asserted-by":"publisher","DOI":"10.1182\/blood-2019-123747"},{"key":"CIT0014","doi-asserted-by":"publisher","DOI":"10.1182\/blood-2021-150751"},{"key":"CIT0015","doi-asserted-by":"publisher","DOI":"10.1038\/s41408-021-00459-7"},{"key":"CIT0016","doi-asserted-by":"publisher","DOI":"10.1182\/bloodadvances.2021005083"},{"key":"CIT0017","doi-asserted-by":"crossref","unstructured":"Ma X, Long L, Moon S, et\u00a0al. Comparison of population characteristics in real-world clinical oncology databases in the US: Flatiron health, SEER, and NPCR. MedRxiv 2020; doi: https:\/\/doi.org\/10.1101\/2020.03.16.20037143.","DOI":"10.1101\/2020.03.16.20037143"},{"issue":"25","key":"CIT0018","first-page":"2745","volume":"131","author":"Hallek M","year":"2018","journal-title":"J Am SocHematol"},{"key":"CIT0019","doi-asserted-by":"publisher","DOI":"10.1016\/j.jval.2017.08.3019"},{"key":"CIT0020","doi-asserted-by":"publisher","DOI":"10.1111\/j.1524-4733.2009.00602.x"},{"key":"CIT0021","doi-asserted-by":"publisher","DOI":"10.1111\/j.1524-4733.2009.00600.x"}],"container-title":["Leukemia &amp; Lymphoma"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.tandfonline.com\/doi\/pdf\/10.1080\/10428194.2023.2190436","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,8,18]],"date-time":"2023-08-18T06:15:33Z","timestamp":1692339333000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.tandfonline.com\/doi\/full\/10.1080\/10428194.2023.2190436"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,3,29]]},"references-count":21,"journal-issue":{"issue":"5","published-print":{"date-parts":[[2023,4,16]]}},"alternative-id":["10.1080\/10428194.2023.2190436"],"URL":"https:\/\/doi.org\/10.1080\/10428194.2023.2190436","relation":{},"ISSN":["1042-8194","1029-2403"],"issn-type":[{"value":"1042-8194","type":"print"},{"value":"1029-2403","type":"electronic"}],"subject":[],"published":{"date-parts":[[2023,3,29]]},"assertion":[{"value":"The publishing and review policy for this title is described in its Aims & Scope.","order":1,"name":"peerreview_statement","label":"Peer Review Statement"},{"value":"http:\/\/www.tandfonline.com\/action\/journalInformation?show=aimsScope&journalCode=ilal20","URL":"http:\/\/www.tandfonline.com\/action\/journalInformation?show=aimsScope&journalCode=ilal20","order":2,"name":"aims_and_scope_url","label":"Aim & Scope"},{"value":"2023-01-10","order":0,"name":"received","label":"Received","group":{"name":"publication_history","label":"Publication History"}},{"value":"2023-02-24","order":1,"name":"revised","label":"Revised","group":{"name":"publication_history","label":"Publication History"}},{"value":"2023-03-09","order":2,"name":"accepted","label":"Accepted","group":{"name":"publication_history","label":"Publication History"}},{"value":"2023-03-29","order":3,"name":"published","label":"Published","group":{"name":"publication_history","label":"Publication History"}}]}}